Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

We have observed 105 EP applications David James Miller has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11749612

CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS

IPC classification:
A61P 19/02, C07K 14/545
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12702092

MATERIALS AND METHOD FOR DETECTING CYTOMEGALOVIRUS (CMV)

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
The patent has been granted
EP12744843

IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES

IPC classification:
A61K 38/00, A61K 39/02, C07H 21/04, C07K 5/00, C12N 15/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12723781

METHODS OF PREVENTING AND REMOVING TRISULFIDE BONDS

IPC classification:
C07K 1/113, C12N 5/00
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11822565

SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN ANIMALS

IPC classification:
A61K 35/28, C12N 5/07, C12N 5/10
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12817042

ASSAYS TO MONITOR BLEEDING DISORDERS

IPC classification:
A61K 38/36, C07K 14/745, G01N 33/48
Applicant:
BIOGEN IDEC HEMOPHILIA INC.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12825669

NOVEL KIF5B-RET FUSION MOLECULES AND USES THEREOF

IPC classification:
C07K 14/82
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12714911

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNBETA AND USES THEREOF

IPC classification:
G01N 33/68
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11737503

THROMBIN GENERATION DETERMINATION METHOD

IPC classification:
C12Q 1/56, G01N 33/50
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12815922

MATERIALS AND METHODS FOR DIAGNOSIS, PROGNOSIS AND ASSESSMENT OF THERAPEUTIC/PROPHYLACTIC TREATMENT OF PROSTATE CANCER

IPC classification:
C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14169178

Methods of treatment using anti-ERBB antibody-maytansinoid conjugates

IPC classification:
A61K 47/48
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13735995

METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY

IPC classification:
C12P 21/04
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14174866

Treatment for multiple sclerosis

IPC classification:
A61K 39/395, A61P 25/28, C07K 16/28
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12818630

METHODS AND APPARATUSES HARVESTING, MODIFYING AND REIMPLANTATION OF DERMAL MICRO -ORGANS

IPC classification:
A61B 17/322, A61K 35/36
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12846452

USE OF AN ANTI-ALPHA-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF ALPHA-SYNUCLEIN IN THE BRAIN

IPC classification:
A61K 39/395, G01N 33/53
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12868427

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 38/37, C07K 14/755
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13749382

RECOMBINANT FACTOR VIII PROTEINS

IPC classification:
A61K 35/14, A61K 38/37
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13735649

CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF

IPC classification:
A61K 38/37
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12180713

Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures

IPC classification:
A61K 39/205, C12N 5/07
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13765090

JCV NEUTRALIZING ANTIBODIES

IPC classification:
C07K 14/24
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13768062

DELIVERY DEVICE AND COMPONENTS THEREOF

IPC classification:
A61M 5/00, A61M 5/315
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14178388

VLA-1 antagonist for use in treating stroke

IPC classification:
A61K 38/19, A61K 39/395, A61P 9/10
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13723287

COGNITIVE COMPOSITE PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS

IPC classification:
A61B 5/16, G06F 19/00
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14190758

Antibodies to troponin I and methods of use therof

IPC classification:
C07K 14/47, C07K 16/18
Applicant:
Abbott Laboratories
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13799785

PROCOAGULANT COMPOUNDS

IPC classification:
A61K 38/02, A61K 38/36, A61P 7/02
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13742451

PRODUCTION OF INFECTIOUS INFLUENZA VIRUSES

IPC classification:
C12N 7/00, C12N 7/02, C12N 15/85
Applicant:
Sanofi Pasteur SA
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13751009

DISEASE PROGRESSION PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS

IPC classification:
A61B 5/00, G06F 19/00
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11843556

STABLE PRESERVED COMPOSITIONS OF INTERFERON-BETA

IPC classification:
C12P 21/04
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11793578

ENRICHMENT AND CONCENTRATION OF SELECT PRODUCT ISOFORMS BY OVERLOADED BIND AND ELUTE CHROMATOGRAPHY

IPC classification:
B01D 15/42
Applicant:
Biogen Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13842864

METHODS OF USING FIX POLYPEPTIDES

IPC classification:
A61K 38/36, A61K 39/395, A61K 47/48, A61P 7/04
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15160028

NOGO receptor binding protein

IPC classification:
A61K 38/00, A61K 38/17, A61K 39/395, A61K 48/00, C07K 14/47, C07K 14/705, C07K 16/18, C07K 16/28, C12N 15/12, C12N 15/62, C12N 15/63, G01N 33/50, G01N 33/68
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15160629

SPECIFIC BINDING PROTEINS AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/30, G01N 33/50, G01N 33/574
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13852306

METHODS OF USING FVIII POLYPEPTIDE

IPC classification:
A61K 39/395
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13814340

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14735224

SYSTEM AND METHOD FOR OUTCOME TRACKING AND ANALYSIS

IPC classification:
G06Q 50/24
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14738023

METHODS FOR IMPROVED PRODUCTION AND RECOVERY OF RECOMBINANT PROTEINS FROM EUKARYOTIC CELL CULTURES

IPC classification:
C12N 5/00, C12N 5/07, C12P 21/04
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP15167892

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/437, A61K 31/496, C07D 471/04, C07D 491/052, C07D 519/00
Applicant:
AbbVie Bahamas Limited
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14737761

MEDIUM SUPPLEMENTS FOR IMPROVED PROCESS PERFORMANCE

IPC classification:
C12N 5/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14745595

ASSAY FOR DETECTION OF JC VIRUS DNA

IPC classification:
C07H 21/00, C07H 21/04, C12Q 1/70
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14702616

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14705304

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14751254

OPTIMIZED FACTOR VIII GENE

IPC classification:
C07K 14/755
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765295

ONE-STEP PROCEDURE FOR THE PURIFICATION OF NUCLEIC ACIDS

IPC classification:
B01D 57/02, C07H 1/06, C12N 15/10, C12Q 1/68, G01N 27/447
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765076

COMPOSITIONS AND METHODS FOR NUCLEIC ACID EXTRACTION

IPC classification:
C12P 19/34
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14764659

FACTOR IX POLYPEPTIDE FORMULATIONS

IPC classification:
A61K 38/48, A61K 39/00, C07K 16/00, C12N 9/96
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13785756

PURIFICATION OF PROTEINS USING HYDROPHOBIC INTERACTION CHROMATOGRAPHY

IPC classification:
A61K 39/395, C07K 1/16, C07K 1/18, C07K 1/20, C07K 1/22, C07K 1/34, C07K 1/36, C07K 16/24
Applicant:
AbbVie Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14765488

HYDROPHOBIC INTERACTION PROTEIN CHROMATOGRAPHY UNDER NO-SALT CONDITIONS

IPC classification:
C07K 1/20, C07K 16/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14715500

LOW ACIDIC SPECIES COMPOSITIONS AND METHODS FOR PRODUCING THE SAME USING DISPLACEMENT CHROMATOGRAPHY

IPC classification:
C07K 1/16, C07K 1/20, C07K 16/06, C07K 16/28
Applicant:
AbbVie Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14722865

ANTIBODY DRUG CONJUGATE (ADC) PURIFICATION

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
AbbVie Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14768286

DEVICE, SYSTEM, METHODS, AND COMPUTER READABLE MEDIA FOR MANAGING ACUTE AND CHRONIC PAIN

IPC classification:
A61N 1/32
Applicant:
The University of North Carolina at Chapel Hill - The Office of Technology Development and Economic Development
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14769555

DETECTION OF BISULFITE CONVERTED NUCLEOTIDE SEQUENCES

IPC classification:
C07H 21/04, C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14725274

METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH

IPC classification:
A61K 38/18, A61P 17/02, A61P 17/14, C07K 14/475
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14760955

DEVICES, SYSTEMS, AND METHODS FOR ACOUSTICALLY -ENHANCED MAGNETOPHORESIS

IPC classification:
B01D 35/06
Applicant:
Duke University - Office of Licensing & Ventures
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14779286

METHODS, COMPOSITIONS, AND KITS FOR DETECTING PROTEASE ACTIVITY IN COMPLEX SAMPLES

IPC classification:
A23K 20/168
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765091

USE OF RAMAN SPECTROSCOPY TO MONITOR CULTURE MEDIUM

IPC classification:
G01J 3/44, G01N 21/65
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14795352

ANALYSIS OF GENETIC VARIANTS

IPC classification:
G06F 7/60, G06F 19/18, G06F 19/22
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15179545

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
PATENT GRANTED
EP14803454

METHODS OF EVALUATING CELL CULTURE ADDITIVES

IPC classification:
A61K 31/765
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15183033

A METHOD FOR THE HIGH LEVEL EXPRESSION OF THE ACTIVE LYMPHOTOXIN-BETA RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION

IPC classification:
A61K 38/00, C07K 19/00, C12N 1/19, C12N 1/21, C12N 5/10
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14734364

METHODS OF TREATING A TAUOPATHY

IPC classification:
A61K 39/395, A61K 51/10, C07K 16/18, C12N 15/63, G01N 33/68
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14818050

THROMBIN CLEAVABLE LINKER

IPC classification:
A61K 38/37
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14817900

THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF

IPC classification:
A61K 38/37
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14820267

COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE

IPC classification:
C07K 16/28
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14835927

RECOMBINANT FACTOR VIII PROTEINS

IPC classification:
A61K 35/14, A61K 38/36, A61K 38/37, C07K 1/00, C07K 14/745, C07K 14/755
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14761736

CONTROL OF PROTEIN GLYCOSYLATION BY CULTURE MEDIUM SUPPLEMENTATION AND CELL CULTURE PROCESS PARAMETERS

IPC classification:
C12N 5/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14840445

CELL-SEEDED COMPOSITIONS AND METHODS USEFUL FOR TREATING BONE REGIONS

IPC classification:
A61K 35/12, A61K 35/32, A61P 19/00
Applicant:
Muffin Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14839440

PRODUCTS COMPRISING AN EXTRACELLULAR MATRIX TISSUE MATERIAL AND OSTEOGENIC PROTEIN

IPC classification:
A61K 35/12, A61K 35/32, A61P 19/00
Applicant:
Muffin Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14766617

TREATMENT METHODS FOR RHEUMATOID ARTHRITIS

IPC classification:
G01N 33/564
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14842369

COMPOSITIONS AND METHODS FOR INCREASING MESENCHYMAL STROMAL CELL MIGRATION TO TUMORS

IPC classification:
G01N 33/574
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12745253

S1P MODULATING AGENTS

IPC classification:
A61K 31/55, A61P 25/00, C07D 211/34, C07D 211/60, C07D 211/62, C07D 401/06, C07D 405/12
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14805362

MICRO-ORGANS PROVIDING SUSTAINED DELIVERY OF A THERAPEUTIC POLYPEPTIDE AND METHODS OF USE THEREOF

IPC classification:
A61B 17/322, A61K 35/36
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP11742896

NEUROPROTECTION IN DEMYELINATING DISEASES

IPC classification:
A61K 31/225, A61K 31/275, A61K 38/16, A61K 38/21, A61P 25/00
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Multiple attorneys, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
David James Miller, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14859449

PROCOAGULANT FUSION COMPOUND

IPC classification:
A61K 38/36
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14867154

POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF

IPC classification:
A61K 38/37
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14827357

USE OF PERFUSION SEED CULTURES TO IMPROVE BIOPHARMACEUTICAL FED-BATCH PRODUCTION CAPACITY AND PRODUCT QUALITY

IPC classification:
C12M 1/34
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15735473

FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

IPC classification:
A61K 38/36
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15710294

USE OF CATION-EXCHANGE CHROMATOGRAPHY IN THE FLOW-THROUGH MODE TO ENRICH POST-TRANSLATIONAL MODIFICATIONS

IPC classification:
C07K 1/18, C07K 14/745, C07K 14/755, C07K 16/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16167345

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

IPC classification:
A61K 47/48, C07K 14/475, C07K 14/505, C07K 14/555, C07K 14/56, C07K 14/565, C07K 14/745, C07K 16/00, C12N 9/64, C12N 9/96
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP14882522

TAU PEPTIDES, ANTI-TAU ANTIBODIES, AND METHODS OF USE THEREOF

IPC classification:
A61K 38/00, A61K 39/00, C12P 21/08, G01N 33/53
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15754919

METHOD OF ASSESSING RISK OF PML

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15716252

METHODS FOR OVERCOMING GLUTAMINE DEPRIVATION DURING MAMMALIAN CELL CULTURE

IPC classification:
C12N 5/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15769411

LYOPHILIZED FACTOR IX FORMULATIONS

IPC classification:
F26B 5/06
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15774029

METHODS OF USING PIGMENT EPITHELIUM DERIVED FACTOR (PEDF) FOR THE TREATMENT AND PREVENTION OF AGENT-INDUCED GONADAL OR UTERINE TOXICITY

IPC classification:
A61K 31/138, A61K 38/18, A61P 15/08
Applicant:
Ramot at Tel-Aviv University Ltd.
Applicant:
Mor Research Applications Ltd.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15718003

ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 39/00, A61P 35/00, C07K 14/00, C07K 16/28, A61K 47/50
Applicant:
AbbVie Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15780065

MEDIUM USED FOR BLOOD SAMPLE COLLECTION AND TRANSPORT

IPC classification:
G01N 1/28
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15724464

BIOMARKERS PREDICTIVE OF LUPUS PROGRESSION AND USES THEREOF

IPC classification:
G01N 33/50, G01N 33/53, G01N 33/567, G01N 33/68
Applicant:
Johns Hopkins University
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16183267

S1P MODULATING AGENTS

IPC classification:
A61K 31/55, A61P 25/00, C07D 211/34, C07D 211/60, C07D 211/62, C07D 401/06, C07D 405/12
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15735743

USE OF AMINOGLYCOSIDE ANALOGS IN THE TREATMENT OF RETT SYNDROME

IPC classification:
A61K 31/7036, A61P 25/00, A61P 43/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15814881

OPTIMIZED FACTOR IX GENE

IPC classification:
A61K 31/7088, C07H 21/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15763443

PEGYLATION METHOD

IPC classification:
C07K 14/435, C07K 14/555, C07K 14/56, C07K 14/565
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16200363

PROTEIN FORMULATIONS AND METHODS OF MAKING SAME

IPC classification:
A61K 9/08, A61K 9/19, A61K 38/21, A61K 38/46, A61K 38/48, A61K 38/50, A61K 39/395
Agent:
David James Miller, Mathys & Squire LLP
Status:
The application has been published
EP15833420

SYSTEM AND METHOD FOR MANAGING GENOMIC INFORMATION

IPC classification:
G06F 19/18, G06F 19/26
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15832334

METHODS OF TREATING CERVICAL CANCER

IPC classification:
A61K 38/03, A61K 38/06, A61P 35/00, C07K 19/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15846772

PATIENT-SPECIFIC IMMUNOTHERAPY FOR TREATING HETEROGENEOUS TUMORS

IPC classification:
A61K 39/395, C12Q 1/68, G01N 33/50, G06F 19/00, G06F 19/24, G06N 3/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP17163411

ANTI-VLA-4 ANTIBODIES

IPC classification:
C07K 16/28
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
The application has been published
EP15778295

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER

IPC classification:
A61P 35/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15778294

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1

IPC classification:
A61P 35/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15794371

COPPER SUPPLEMENTATION FOR CONTROL OF GLYCOSYLATION IN MAMMALIAN CELL CULTURE PROCESS

IPC classification:
C12N 5/00, C12P 21/06
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15794425

HYPOTAURINE, GABA, BETA-ALANINE, AND CHOLINE FOR CONTROL OF WASTE BYPRODUCT ACCUMULATION IN MAMMALIAN CELL CULTURE PROCESS

IPC classification:
C12N 5/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15797085

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/46
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15804458

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES

IPC classification:
A61P 35/00, C07K 16/28, G01N 33/574
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15868614

MARKER COMBINATIONS FOR DIAGNOSING INFECTIONS AND METHODS OF USE THEREOF

IPC classification:
G01N 33/569
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15871055

COMPUTER-IMPLEMENTED SYSTEM AND METHOD FOR IDENTIFYING SIMILAR PATIENTS

IPC classification:
G06F 19/18, G06F 19/28
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15866246

MULTIGENE ANALYSIS OF TUMOR SAMPLES

IPC classification:
A61K 39/395, C12Q 1/68, C40B 20/00, C40B 20/04, C40B 40/06, C40B 50/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP16703864

LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/28
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature